Drugs / MLF 541
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00798447 | Nov 2008 → Oct 2010 | digestive system cancer | B. Braun Melsungen AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MLF 541 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00798447 ↗ |
| Route | Intravenous | “22-24 h i.v. infusion” NCT00798447 ↗ |